Haim Zaltzman
Haim Zaltzman, Global Vice Chair of Latham's Emerging Companies & Growth Practice, focuses on private capital, finance, and other corporate transactions, primarily in the healthcare, life sciences, and technology fields. Haim is a member of the firm's Strategic Client Committee and Private Capital Practice. Haim frequently represents borrowers/issuers, sponsors, and financial institutions in private capital transactions, including: Technology growth financings (venture, structured, ABL, ARR, CARR/bookings, milestone-based, Up C, SPAC-related, and other structures) Direct lending transactions (private equity acquisition financings, cash-flow, ARR, CARR, liquidity, and other structures) Life sciences intellectual property monetization transactions (IP-backed debt, royalty buyout, synthetic royalty, revenue participations, R&D financings) Leasing, crypto/bitcoin, securitization, and other similar asset-based transactions Structured equity, pre-IPO debt and equity financings, and similar private capital transactions Haim holds leadership positions with the Chinese American International School and the American Jewish Committee. Haim has also been featured on CNBC, The Information, Bloomberg, The Washington Post, CFO Magazine, The Recorder, Law360.com, The Daily Journal, the International Financial Law Review, and VCExperts.com for his debt experience. · Latham & Watkins
About
Global Vice Chair of Latham's Emerging Companies & Growth Practice focusing on private capital, finance, and corporate transactions in healthcare, life sciences, and technology.